Bayer

March 2, 2015

Xarelto Wrongful Death Lawsuits Ramping Up

According to court documents and a review of the inventory of filed lawsuits against the makers of Xarelto, the litigation appears to be gathering steam and increasing in breadth and depth. In December 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) granted consolidated pretrial proceedings for all federal Xarelto cases filed against Bayer and Johnson & Johnson’s Janssen subsidiary over the new-generation blood thinner.

Xarelto Personal Injury Bleeding and Death Cases Over 220

The Xarelto personal injury and product liability claims are centralized before U.S. District Judge Eldon E. Fallon in the Eastern District of Louisiana.Bayer and Johnson & Johnson is now exposed to at least 220 bleeding cases in the federal multi-district litigation (MDL), with more on the way.

December 18, 2014

Xarelto Louisiana MDL For Uncontrollable Bleeding Lawsuits

by Dr. Shezad Malik

The U.S. Judicial Panel on Multidistrict Litigation announced consolidation and centralization of all nationwide Xarelto lawsuits filed in federal courts before U.S. District Judge Eldon E. Fallon in the Eastern District of Louisiana.

Over 50 Federal Xarelto Lawsuits

Bayer Healthcare and Johnson & Johnson’s Janssen Pharmaceuticals subsidiary are exposed to at least 50 product liability lawsuits over their new-generation anticoagulant. These personal injury and wrongful death claims are pending in 24 different federal courts.

December 4, 2014

Xarelto MDL Consolidation Hearing

by Dr. Shezad Malik

Today, the U.S. Judicial Panel on Multidistrict Litigation (JPML) heard oral arguments to consolidate all federal Xarelto lawsuits before one judge, in one centralized U.S. District Court.

It is widely anticipated that the U.S. JPML will establish centralized proceedings for coordinated discovery and a series of bellwether trials.

Patients who took Xarelto accuse the drug manufacturers of downplaying Xarelto’s bleeding risks and asked that the cases be sent to U.S District Judge David Herndon in East St. Louis, Illinois. An order maybe granted before the upcoming holiday season.

October 11, 2014

J&J Janssen’s Xarelto Anticoagulant Side-Effects

by Dr. Shezad Malik

Anticoagulation therapy is necessary in several serious medical conditions including a common heart rhythm abnormality, known as atrial fibrillation, deep vein thrombosis, pulmonary embolism and in certain genetic blooding clotting diseases.

The medications reduce the incidence of blood clots and reduce the rate of strokes as in the case of atrial fibrillation and to prevent catastrophic injuries from pulmonary embolism including death.

Untreated deep vein thrombosis (blood clot in the leg) can result in a pulmonary embolism when the blood clot in the leg breaks off and travels in the venous system to the lung.

September 30, 2014

Illinois Xarelto Bleeding Death Lawsuit

by Dr. Shezad Malik

Bayer Healthcare and Johnson & Johnson’s Janssen Pharmaceuticals subsidiary, the manufacturers of the novel oral anticoagulant (NOACS) Xarelto, are exposed to several Xarelto product liability personal injury lawsuits, filed nationwide.

These have brought by folks who suffered a catastrophic injury or death due to uncontrollable bleeding side effects while on the popular anticoagulant drug.

Illinois Xarelto Wrongful Death Lawsuit

September 13, 2014

California Xarelto Hemorrhage Lawsuit Over Inadequate Warnings

by Dr. Shezad Malik

Recently Shirley Boynton from California filed a product liability lawsuit against Bayer Healthcare and Johnson & Johnson’s Janssen subsidiary claiming that she almost died from uncontrollable hemorrhaging after using the new anticoagulant medication Xarelto.

The complaint was filed in the U.S. District Court for the Eastern District of New York. Boynton alleges that she suffered permanent injuries as a result inadequate Xarelto hemorrhage warnings provided to patients and doctors.

Xarelto: Dangerous and Defective Allegations

August 13, 2014

New York Xarelto Uncontrollable Bleeding Lawsuit

by Dr. Shezad Malik

A Texas woman is the latest to sue Bayer and Johnson & Johnson pharmaceutical companies, claiming that the anticoagulant Xarelto has inadequate warnings about the bleeding risk associated with the drug. Jeanne Jeffcoat filed the lawsuit in the U.S. District Court for the Eastern District of New York, she claimed that Xarelto caused life-threatening bleeding event that left her permanently injured.

There are many defective drug product liability lawsuits filed nationwide over bleeding and hemorrhage side effects of Xarelto.

Xarelto Aggressive Marketing

August 1, 2014

Xarelto Bleeding Wrongful Death Lawsuit

by Dr. Shezad Malik

A Vermont man who suffered deadly brain bleed has filed a wrongful death lawsuit. The family alleges that the death was caused by side effects of Xarelto, a new generation anticoagulant. Xarelto, has recently come under fire from its irreversible bleeding side effects and is the subject of many similar lawsuits.

Thomas C. Dunkley’s daughter Ruth McGowen, filed a claim against Bayer Healthcare and Johnson & Johnson’s Janssen Pharmaceuticals subsidiary on July 25, in the U.S. District Court for the District of Vermont.

According to the Xarelto allegations, Dunkley was prescribed the blood thinner anticoagulant in July 2012, for treatment of atrial fibrillation to reduce the risk of a embolic stroke.

January 7, 2014

Mirena IUD Perforation New Jersey and New York Lawsuits

by Dr. Shezad Malik

Product liability lawsuits over Mirena IUD uterus perforation injuries continues to climb in state and federal court. There are more than 600 Mirena IUD lawsuits filed nationwide. The women allege that they suffered debilitating injuries when their Mirena IUD birth control perforated the uterus, causing internal injuries, and requiring surgical removal of the Mirena implant.

Federal Court New York MDL

About 300 cases are filed in the federal court system, and centralized for pretrial proceedings before U.S. District Judge Seibel in the Southern District of New York as part of an MDL, or multidistrict litigation.

November 9, 2013

Bayer has Settled $1.6 Billion Yaz and Yasmin Blood Clot Lawsuits

by Dr. Shezad Malik

According to Bayer, the pharmaceutical giant has paid out more than $1.6 billion in settlements over Yasmin and Yaz blood clot embolism injuries. The German drug manufacturer is exposed to thousands of product liability drug claims that allege that women suffered severe blood clots due to dangerous side effects of the birth control pills. Bayer has been settling these injury cases over the past 2 years.

Bayer 3rd Quarter Report